Skip to main content
UniHealth

Doctor search

Tara I Hsin Chang, MD

Nephrology · Stanford

NPI 1437166592

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
15
4 carriers
Office
1
Since medical school
23 years
University of Michigan Medical School, 2003

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plans that list them

15 plans · 4 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chang’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

15 of 15 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
Anthem Full Dual Advantage Aligned (HMO D-SNP)Anthem Blue CrossListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A90280 · Current

Licensed to practise in California · since 2005 · expires 2028-10-31 · University of Michigan Medical School.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Internal Medicine - Internal Medicine
  • American Board of Internal Medicine - Nephrology

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$48,901

Medicare paid this office $48,901 for 208 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes40$6,639$71
Return visit (30+ min)41$5,493$100
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes23$4,567$106
Long return visit (40+ min)21$4,339$145
Dialysis procedure including 1 evaluation11$3,783$79
See all 13 services
Every Original Medicare service billed
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes40$6,639$71
Return visit (30+ min)41$5,493$100
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes23$4,567$106
Long return visit (40+ min)21$4,339$145
Dialysis procedure including 1 evaluation11$3,783$79
Long return visit (40+ min)16$2,799$122
Return visit (30+ min)25$2,268$73
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes16$1,987$117
Hemodialysis procedure with physician evaluation12$1,137$63
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes18$879$42
Ambulatory blood pressure monitoring, 1 day or longer, with review, interpretation and report39$602$15
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's32$569$15
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's19$300$15

Who their Medicare patients are

208 Original Medicare patients in 2024. Average age 72 · Under 65 17% · 85 and older 13% · Women 50% · Also on Medicaid 29% · Health risk score 3.34. At or below the middle of the specialty; the typical nephrology clinician is at 4.01.

Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 49% · Coronary heart disease 46% · Heart failure 40% · Atrial fibrillation 35% · Depression 25% · Cancer 21% · Stroke 20% · COPD 19% · Dementia 14%.

The office billed $221,631, Medicare allowed $64,360 and paid $48,901; for 583 services of 22 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024208583723.34$221,631$48,901
2023243575714.58$220,551$49,061
2022278697724.24$268,711$55,351
2021257714703.83$300,821$59,843
2020217625694.15$221,729$45,184
2019189478684.77$128,650$32,816
2018164396664.62$101,556$24,800
2017172477684.52$115,994$29,985
2016171462704.23$103,780$26,295
2015191534674.76$121,104$30,896
2014146358684.73$84,082$22,363
2013104232703.71$66,875$17,309

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 11 services

Original Medicare services billed in 2023
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes67$8,172$73
Return visit (30+ min)47$4,874$80
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes39$4,544$117
Dialysis procedure including 1 evaluation16$4,033$81
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes55$3,703$45
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes23$2,852$110
Return visit (30+ min)30$2,793$82
Long return visit (40+ min)17$2,793$133
Hemodialysis procedure with physician evaluation22$1,706$66
Short return visit (20+ min)24$1,332$49
Ambulatory blood pressure monitoring, 1 day or longer, with review, interpretation and report12$202$17

2022: 12 services

Original Medicare services billed in 2022
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes80$10,622$65
Return visit (30+ min)52$5,211$77
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes30$4,695$94
Dialysis procedure including 1 evaluation17$3,897$81
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes69$3,814$35
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes26$3,196$123
Long return visit (40+ min)21$3,067$118
Return visit (30+ min)19$2,316$89
Hemodialysis procedure with physician evaluation22$1,935$67
Short return visit (20+ min)30$1,650$50
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes14$1,263$90
Short return visit (20+ min)14$733$52

2021: 13 services

Original Medicare services billed in 2021
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes76$11,419$66
Return visit (30+ min)52$5,669$85
Long return visit (40+ min)32$5,509$134
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes29$4,868$95
Dialysis procedure including 1 evaluation21$4,335$82
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes28$3,508$125
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes51$3,265$35
Return visit (30+ min)22$2,289$85
New patient visit (60+ min)14$2,243$160
Short return visit (20+ min)29$1,992$60
Long return visit (40+ min)14$1,791$119
Hemodialysis procedure with physician evaluation17$1,282$67
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes13$1,198$92

2020: 12 services

Original Medicare services billed in 2020
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes75$11,864$67
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes28$3,576$128
Return visit (30+ min)40$3,434$65
Dialysis procedure including 1 evaluation17$3,199$82
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes27$3,194$97
New patient visit (60+ min)19$2,907$153
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes36$1,936$37
Short return visit (20+ min)31$1,782$48
Hemodialysis procedure with physician evaluation16$1,706$68
Long return visit (40+ min)20$1,552$74
Return visit (30+ min)11$732$67
Short return visit (20+ min)11$518$47

2019: 10 services

Original Medicare services billed in 2019
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes43$5,677$66
Return visit (30+ min)45$4,648$69
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes59$3,374$36
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes20$2,475$124
Dialysis procedure including 1 evaluation15$2,380$79
Hemodialysis procedure with physician evaluation23$2,191$64
Long return visit (40+ min)15$1,514$89
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes12$1,509$94
Short return visit (20+ min)27$1,300$39
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes11$999$91

2018: 8 services

Original Medicare services billed in 2018
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes66$4,511$35
Short return visit (20+ min)52$3,484$43
Dialysis procedure including 1 evaluation13$2,421$78
Return visit (30+ min)24$2,331$65
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes24$1,896$65
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes12$1,467$122
Hemodialysis procedure with physician evaluation15$1,234$65
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes11$988$90

2017: 7 services

Original Medicare services billed in 2017
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes86$5,624$35
Short return visit (20+ min)48$3,320$43
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes30$3,109$65
Return visit (30+ min)24$2,469$69
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes22$2,063$90
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes15$1,831$122
Hemodialysis procedure with physician evaluation14$1,030$64

2016: 7 services

Original Medicare services billed in 2016
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes66$5,383$34
Short return visit (20+ min)60$3,831$39
Return visit (30+ min)32$3,642$65
Hemodialysis procedure with physician evaluation21$2,134$65
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes26$2,120$61
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes19$1,695$89
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes11$1,336$121

2015: 8 services

Original Medicare services billed in 2015
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes64$7,707$65
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes85$5,952$35
Short return visit (20+ min)47$3,461$41
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes23$2,808$122
Return visit (30+ min)24$2,384$66
Hemodialysis procedure with physician evaluation31$2,194$65
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes23$2,156$90
New patient visit (60+ min)12$1,684$140

2014: 8 services

Original Medicare services billed in 2014
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes44$5,316$64
New patient visit (60+ min)24$3,244$135
Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes38$2,811$35
Short return visit (20+ min)38$2,547$40
Initial hospital care with straightforward or low-level medical decision making at least 55 minutes20$2,434$122
Return visit (30+ min)19$1,477$57
Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes11$1,071$89
Hemodialysis procedure with physician evaluation13$968$65

2013: 6 services

Original Medicare services billed in 2013
Subsequent hospital care with moderate levelof medical decision making at least 35 minutes39$4,345$62
Initial hospital care with moderate level of medical decision making at least 75 minutes14$2,442$174
Subsequent hospital care with moderate levelof medical decision making at least 50 minutes16$2,057$89
New patient visit (60+ min)12$1,739$145
Return visit (30+ min)22$1,693$56
Short return visit (20+ min)25$1,010$36

Medicaid work

$5,021 in 2023

Medicaid paid $5,021 for 130 billed services this clinician did in 2023, up to 20 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2023
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES113$4,449
SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES17$573
Medicaid work by year
2023130220$5,021
2022123215$2,887
2021100216$1,991
202085116$2,806
201926114$438
See the largest Medicaid services in earlier years

2022

Largest Medicaid services in 2022
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES99$2,436
SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES24$451

2021

Largest Medicaid services in 2021
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES47$1,041
SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES53$950

2020

Largest Medicaid services in 2020
SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES85$2,806

2019

Largest Medicaid services in 2019
SBSQ HOSPITAL IP/OBS CARE SF/LOW MDM 25 MINUTES26$438

Drugs they prescribed that Part D paid

$206,472

Pharmacies billed $206,472 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

514 generic and 143 brand-name prescriptions · $206,472 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Farxiga42$55,822$1,329
Jardiance32$40,294$1,259
Aranesp12$26,545$2,212
Veltassa11$26,228$2,384
Procrit11$5,113$465
See all 20 drugs
Every Part D drug this clinician prescribed
Farxiga42$55,822$1,329
Jardiance32$40,294$1,259
Aranesp12$26,545$2,212
Veltassa11$26,228$2,384
Procrit11$5,113$465
Losartan48$658$14
Doxazosin Mesylate24$531$22
Calcitriol13$514$40
Carvedilol44$421$10
Spironolactone33$412$12
Potassium Chloride16$374$23
Chlorthalidone31$366$12
Nifedipine Er12$331$28
Amlodipine Besylate47$310$7
Allopurinol26$282$11
Telmisartan13$277$21
Furosemide23$218$9
Atorvastatin19$102$5
Hydrochlorothiazide11$50$5
Metoprolol13$23$2

Year by year

Part D prescribing by year
2024657104None22%$206,472
2023637111None20%$202,021
20226621170% (0)15%$130,079
20215871030% (0)11%$73,285
202053876None12%$46,382
201956065None13%$67,774
201845057None15%$57,873
201742953None19%$71,632
2016513570% (0)17%$51,651
2015427450% (0)17%$34,510
2014335420% (0)18%$18,931
201324441None25%$12,260

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 17 drugs

Part D drugs prescribed in 2023
Farxiga39$57,780$1,482
Jardiance25$34,659$1,386
Veltassa13$20,256$1,558
Eplerenone13$1,203$93
Losartan61$1,163$19
Chlorthalidone38$936$25
Amlodipine Besylate61$836$14
Doxazosin Mesylate23$823$36
Telmisartan12$801$67
Carvedilol34$528$16
Spironolactone27$439$16
Hydralazine16$322$20
Furosemide16$257$16
Allopurinol17$200$12
Lisinopril15$182$12
Atorvastatin18$159$9
Hydrochlorothiazide16$118$7

2022: 18 drugs

Part D drugs prescribed in 2022
Farxiga36$54,085$1,502
Eplerenone17$1,604$94
Chlorthalidone51$1,092$21
Losartan49$778$16
Carvedilol27$680$25
Amlodipine Besylate56$633$11
Allopurinol25$616$25
Spironolactone28$556$20
Torsemide12$554$46
Furosemide27$474$18
Doxazosin Mesylate23$364$16
Calcitriol16$316$20
Felodipine Er11$241$22
Hydralazine18$228$13
Indapamide11$180$16
Hydrochlorothiazide24$141$6
Lisinopril13$114$9
Atorvastatin15$86$6

2021: 17 drugs

Part D drugs prescribed in 2021
Farxiga23$27,635$1,202
Candesartan Cilexetil13$1,743$134
Chlorthalidone58$1,659$29
Potassium Chloride19$1,088$57
Losartan38$696$18
Torsemide13$690$53
Spironolactone31$610$20
Amlodipine Besylate59$585$10
Calcitriol20$531$27
Carvedilol29$472$16
Allopurinol17$400$24
Atorvastatin13$320$25
Doxazosin Mesylate14$244$17
Furosemide18$184$10
Hydralazine15$136$9
Lisinopril15$72$5
Hydrochlorothiazide15$69$5

2020: 18 drugs

Part D drugs prescribed in 2020
Jardiance13$6,735$518
Mycophenolate Mofetil11$3,431$312
Potassium Chloride15$2,348$157
Chlorthalidone65$2,307$35
Candesartan Cilexetil13$1,053$81
Torsemide15$618$41
Amlodipine Besylate57$560$10
Allopurinol22$524$24
Losartan26$502$19
Carvedilol33$493$15
Rosuvastatin14$481$34
Furosemide18$390$22
Spironolactone17$367$22
Atorvastatin13$207$16
Prednisone12$119$10
Lisinopril23$102$4
Pantoprazole14$74$5
Hydrochlorothiazide11$56$5

2019: 17 drugs

Part D drugs prescribed in 2019
Cinacalcet11$14,292$1,299
Mycophenolate Mofetil12$2,953$246
Candesartan Cilexetil15$2,657$177
Chlorthalidone59$2,446$41
Eplerenone15$1,375$92
Metolazone12$1,125$94
Carvedilol36$743$21
Potassium Chloride19$736$39
Amlodipine Besylate49$697$14
Furosemide28$583$21
Allopurinol19$557$29
Losartan24$440$18
Hydralazine12$237$20
Lisinopril15$216$14
Atorvastatin11$175$16
Amlodipine Besylate-Benazepril11$144$13
Prednisone13$133$10

2018: 14 drugs

Part D drugs prescribed in 2018
Renvela11$26,198$2,382
Eplerenone19$2,423$128
Chlorthalidone48$1,846$38
Doxazosin Mesylate19$1,731$91
Metolazone11$1,214$110
Carvedilol32$701$22
Potassium Chloride12$486$40
Amlodipine Besylate39$432$11
Allopurinol15$325$22
Rosuvastatin15$304$20
Lisinopril12$223$19
Furosemide17$210$12
Losartan19$208$11
Prednisone13$133$10

2017: 12 drugs

Part D drugs prescribed in 2017
Renvela11$25,598$2,327
Eplerenone25$3,930$157
Chlorthalidone51$2,084$41
Doxazosin Mesylate11$1,103$100
Amlodipine Besylate46$483$11
Rosuvastatin12$370$31
Losartan23$293$13
Atorvastatin20$283$14
Allopurinol15$277$18
Carvedilol34$249$7
Furosemide21$183$9
Spironolactone11$180$16

2016: 14 drugs

Part D drugs prescribed in 2016
Chlorthalidone58$2,477$43
Doxazosin Mesylate22$1,805$82
Potassium Citrate Er11$752$68
Losartan39$596$15
Amlodipine Besylate74$451$6
Metoprolol13$391$30
Atorvastatin24$326$14
Carvedilol45$305$7
Calcitriol12$286$24
Allopurinol14$272$19
Furosemide33$249$8
Metoprolol15$219$15
Simvastatin14$116$8
Lisinopril12$76$6

2015: 9 drugs

Part D drugs prescribed in 2015
Chlorthalidone52$1,467$28
Losartan50$545$11
Amlodipine Besylate69$426$6
Metoprolol17$264$16
Spironolactone13$252$19
Atorvastatin11$231$21
Carvedilol28$141$5
Furosemide17$87$5
Calcitriol11$80$7

2014: 9 drugs

Part D drugs prescribed in 2014
Diovan20$5,724$286
Losartan37$741$20
Chlorthalidone36$624$17
Amlodipine Besylate42$293$7
Calcitriol16$266$17
Atorvastatin14$156$11
Triamterene-Hydrochlorothiazid11$121$11
Simvastatin11$94$9
Furosemide22$74$3

2013: 8 drugs

Part D drugs prescribed in 2013
Diovan14$5,642$403
Calcitriol15$607$40
Amlodipine Besylate59$501$8
Atorvastatin13$342$26
Losartan22$311$14
Chlorthalidone14$197$14
Carvedilol12$109$9
Furosemide12$92$8

Money from drug and device companies

$11,846 in 2025

Industry payments by year
202549$11,454$11,846
2024215$6,545$8,413
202213$5,160$5,160
202129$12,000$12,125
202011$2,160$2,160
201925$1,950$2,572

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
AstraZeneca Pharmaceuticals LPFarxiga$11,454
4 payments
  • Consulting for Farxiga · 2025-08-18 · $2,083
  • Consulting for Farxiga · 2025-07-15 · $1,190
  • Consulting for Farxiga · 2025-07-11 · $6,248
  • Consulting for Farxiga · 2025-06-26 · $1,934
Travere TherapeuticsFilspari$138
3 payments
  • Meals · 2025-10-29 · $132
  • Education for Filspari · 2025-10-03 · $2
  • Education for Filspari · 2025-10-03 · $4
AstraZeneca UKNone$135
1 payment
  • Meals · 2025-11-06 · $135
AstraZeneca ABNone$120
1 payment
  • Meals · 2025-11-08 · $120
See all 9 published payments
Every published payment
AstraZeneca ABMeals · 2025-11-08None$120
AstraZeneca UKMeals · 2025-11-06None$135
Travere TherapeuticsMeals · 2025-10-29None$132
Travere TherapeuticsEducation · 2025-10-03Filspari$2
Travere TherapeuticsEducation · 2025-10-03Filspari$4
AstraZeneca Pharmaceuticals LPConsulting · 2025-08-18Farxiga$2,083
AstraZeneca Pharmaceuticals LPConsulting · 2025-07-15Farxiga$1,190
AstraZeneca Pharmaceuticals LPConsulting · 2025-07-11Farxiga$6,248
AstraZeneca Pharmaceuticals LPConsulting · 2025-06-26Farxiga$1,934
See earlier years (2024, 2022, 2021, 2020, 2019)

2024: $8,413

Payments by company in 2024
AstraZeneca UKNone$6,595
2 payments
  • Meals · 2024-10-24 · $50
  • Consulting · 2024-10-21 · $6,545
Alexion PharmaceuticalsNone$1,819
13 payments
  • Meals · 2024-09-19 · $60
  • Meals · 2024-09-19 · $40
  • Travel · 2024-09-19 · $204
  • Meals · 2024-09-19 · $135
  • Travel · 2024-09-19 · $197
  • Meals · 2024-09-19 · $40
  • Meals · 2024-09-19 · $50
  • Travel · 2024-09-19 · $197
  • Meals · 2024-09-19 · $60
  • Meals · 2024-09-19 · $135
  • Meals · 2024-09-19 · $50
  • Meals · 2024-09-19 · $40
  • Travel · 2024-08-19 · $611

2022: $5,160

Payments by company in 2022
Bayer HealthCare PharmaceuticalsNone$5,160
3 payments
  • Consulting · 2022-12-23 · $1,080
  • Consulting · 2022-07-26 · $2,400
  • Consulting · 2022-05-13 · $1,680

2021: $12,125

Payments by company in 2021
Bayer HealthCare PharmaceuticalsNon-Covered$12,000
8 payments
  • Consulting for Non-Covered · 2021-12-28 · $1,680
  • Consulting for Non-Covered · 2021-11-03 · $1,200
  • Consulting for Non-Covered · 2021-10-08 · $1,680
  • Consulting for Non-Covered · 2021-08-13 · $1,440
  • Consulting for Non-Covered · 2021-08-05 · $1,680
  • Consulting for Non-Covered · 2021-03-17 · $1,440
  • Consulting for Non-Covered · 2021-03-17 · $1,440
  • Consulting for Non-Covered · 2021-03-15 · $1,440
Ablative SolutionsNone$125
1 payment
  • Meals · 2021-07-27 · $125

2020: $2,160

Payments by company in 2020
Bayer HealthCare PharmaceuticalsNone$2,160
1 payment
  • Consulting · 2020-11-23 · $2,160

2019: $2,572

Payments by company in 2019
AstraZeneca Pharmaceuticals LPFarxiga$2,476
4 payments
  • Consulting for Farxiga · 2019-11-24 · $1,950
  • Travel for Farxiga · 2019-11-09 · $401
  • Meals for Farxiga · 2019-11-09 · $115
  • Meals for Farxiga · 2019-11-09 · $10
Gilead SciencesNone$96
1 payment
  • Meals · 2019-11-08 · $96

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Novo Nordisk AS · Ozempic · 2023This clinician$12,600
Novo Nordisk AS · Ozempic · 2022This clinician$6,550
Novo Nordisk AS · Rybelsus · 2023This clinician$6,050
Novo Nordisk AS · Rybelsus · 2022This clinician$5,750
Novo Nordisk AS · Rybelsus · 2024This clinician$5,525
Novo Nordisk AS · Wegovy · 2022This clinician$4,925
Novo Nordisk AS · Ozempic · 2024This clinician$4,175
Novo Nordisk AS · Wegovy · 2021This clinician$3,450
Eli Lilly and Company · A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Event-Driven Study To Investigate the Effect of Retatrutide on the Incidence of Major Adverse Cardiovascular Events and the Decline in Kidney Function in Participants With Body Mass Index Greater Than 27 Kg M2 and Atherosclerotic Cardiovascular Disease and Or Chronic Kidney Disease · 2025This clinician$3,263
Novo Nordisk AS · 2020This clinician$3,175
Novo Nordisk AS · Ozempic · 2021This clinician$3,000
Novo Nordisk AS · Rybelsus · 2021This clinician$2,350
Novo Nordisk AS · Wegovy · 2023This clinician$2,275
Novo Nordisk AS · Rybelsus · 2020This clinician$2,000
Gilead Sciences, Inc. · A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Selonsertib in Subjects With Moderate To Advanced Diabetic Kidney Disease · 2019This clinician$1,985
Novo Nordisk AS · Ozempic · 2020This clinician$1,050
Novo Nordisk AS · 2019This clinician$800
Eli Lilly and Company · A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Event-Driven Study To Investigate the Effect of Retatrutide on the Incidence of Major Adverse Cardiovascular Events and the Decline in Kidney Function in Participants With Body Mass Index Greater Than 27 Kg M2 and Atherosclerotic Cardiovascular Disease and Or Chronic Kidney Disease · 2025Their institution$675

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.5 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1437166592
Licence
CA A90280California A90280: Current · expires 2028-10-31
Trained
University of Michigan Medical School, 2003 · 23 years ago
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
Yes
Taxonomy
Federal specialty code 207RN0300X (207RN0300X); Internal medicine (207R00000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2006-08-02
NPI last updated
2024-04-17
NPI record certified
2024-04-17

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 300 Pasteur Drive A160, Palo Alto, CA, 94304